PL360468A1 - Treatment and prevention of cardiac insulin resistance associated conditions - Google Patents

Treatment and prevention of cardiac insulin resistance associated conditions

Info

Publication number
PL360468A1
PL360468A1 PL36046800A PL36046800A PL360468A1 PL 360468 A1 PL360468 A1 PL 360468A1 PL 36046800 A PL36046800 A PL 36046800A PL 36046800 A PL36046800 A PL 36046800A PL 360468 A1 PL360468 A1 PL 360468A1
Authority
PL
Poland
Prior art keywords
prevention
treatment
insulin resistance
associated conditions
resistance associated
Prior art date
Application number
PL36046800A
Other languages
Polish (pl)
Inventor
Ameet Nathwani
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of PL360468A1 publication Critical patent/PL360468A1/en

Links

PL36046800A 1999-06-14 2000-06-16 Treatment and prevention of cardiac insulin resistance associated conditions PL360468A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9913781.2A GB9913781D0 (en) 1999-06-14 1999-06-14 Novel compounds

Publications (1)

Publication Number Publication Date
PL360468A1 true PL360468A1 (en) 2004-09-06

Family

ID=10855293

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36046800A PL360468A1 (en) 1999-06-14 2000-06-16 Treatment and prevention of cardiac insulin resistance associated conditions

Country Status (2)

Country Link
GB (1) GB9913781D0 (en)
PL (1) PL360468A1 (en)

Also Published As

Publication number Publication date
GB9913781D0 (en) 1999-08-11

Similar Documents

Publication Publication Date Title
AU3112899A (en) Rf diathermy and faradic muscle stimulation treatment
HK1045111B (en) (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes
GB2368794B (en) Prevention and treatment of amyloidogenic disease
SG93852A1 (en) Enhanced radiopacity of peripheral and central catheter tubing
EP1289584A4 (en) Reaccessible medical needle safety devices and methods
AU2003297356A8 (en) Prevention and treatment of cardiac arrhythmias
HK1045375A1 (en) Surface treatment of medical devices with reactivehydrophilic polymers
AU9275901A (en) Subcutaneous only implantable cardioverter-defibrillator and optional pacer
HUP0201205A3 (en) Prevention and treatment of amyloidogenic disease
EG21712A (en) Treatment of insulin resistance
EG25289A (en) Monitor of living lissue streength and electrical resistance and activity.
IL145502A0 (en) Transdermal therapeutic system with nicotine and addition of monoterpene ketones
IL138692A0 (en) Treatment and prevention of vascular disease
IL132972A0 (en) Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders
GB9911772D0 (en) Diagnosis and treatment of atherosclerosis
HUP0201966A2 (en) Methods of treatment and drug screening methods
GB9922752D0 (en) Medical devices and treatment and prophylaxis
LU91070B1 (en) Treatment and diagnosis of insulin resistant states
PL360468A1 (en) Treatment and prevention of cardiac insulin resistance associated conditions
AU2003231279A8 (en) Prevention and treatment of type 2 diabetes
IL153452A0 (en) Treatment and prevention of cardiac insulin resistance associated conditions
GB9908059D0 (en) Diagnosis and treatment of diseases
EP1173189A4 (en) Asialocytokines and treatment of liver disease
HUP0300043A3 (en) Method and composition for the treatment of pain
GB9726745D0 (en) Treatment of medical conditions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)